Market Overview

Benzinga's Top Downgrades

Related ATU
Benzinga's Top Upgrades, Downgrades For June 22, 2017
Earnings Scheduled For June 21, 2017
Related XYL
Benzinga's Top Upgrades, Downgrades For June 21, 2017
Benzinga's Top Upgrades, Downgrades For May 15, 2017

Analysts at Citigroup downgraded Actuant (NYSE: ATU) from “buy” to “neutral.” Actuant's shares closed at $25.81 yesterday. Actuant's trailing-twelve-month ROE is 14.43%.

Analysts at Goldman downgraded Xylem (NYSE: XYL) from “neutral” to “sell.” Xylem's shares closed at $24.29 yesterday. Xylem's PEG ratio is 2.33.

Analysts at Bernstein downgraded Weatherford International Ltd (NYSE: WFT) from “outperform” to “market perform.” Weatherford's shares closed at $12.24 yesterday. Weatherford's trailing-twelve-month profit margin is 2.53%.

JMP Securities downgraded Anthera Pharmaceuticals (NASDAQ: ANTH) from “outperform” to “market perform.” Anthera Pharmaceuticals' shares closed at $2.75 yesterday. Anthera Pharmaceuticals' trailing-twelve-month ROA is -92.62%.

Latest Ratings for ATU

Jun 2017Gabelli & Co.UpgradesHoldBuy
Jun 2017BarclaysUpgradesUnderweightEqual-Weight
Mar 2017KeyBancUpgradesSector WeightOverweight

View More Analyst Ratings for ATU
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (ATU + ANTH)

View Comments and Join the Discussion!